Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apogee Therapeutics, Inc. | 1,117,328 | reported | 13 May 2026 | tx 46+1,020,064−376,500 |
| Spyre Therapeutics, Inc. | 8,026 | reported | 27 May 2026 | tx 9+212,955−80,000 |
| BridgeBio Pharma, Inc. | 3,137 | reported | 15 Dec 2020 | tx 87+758,655−413,420 |
| ARYA Sciences Acquisition Corp IV | 0 | reported | 31 Jul 2024 | tx 1−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Spyre Therapeutics, Inc. | 8,026 | 0.00 USD | deriv |
| 13 May 2026 | SALE | Apogee Therapeutics, Inc. | 18,659 | 82.05 USD | 10b5-1 |
| 13 May 2026 | SALE | Apogee Therapeutics, Inc. | 1,341 | 82.58 USD | 10b5-1 |
| 08 May 2026 | SALE | Spyre Therapeutics, Inc. | 2,404 | 72.57 USD | 10b5-1 |
| 08 May 2026 | SALE | Spyre Therapeutics, Inc. | 33,513 | 73.72 USD | 10b5-1 |
| 08 May 2026 | SALE | Spyre Therapeutics, Inc. | 24,814 | 74.76 USD | 10b5-1 |
| 08 May 2026 | SALE | Spyre Therapeutics, Inc. | 19,269 | 75.35 USD | 10b5-1 |
| 16 Apr 2026 | EXERCISE | Apogee Therapeutics, Inc. | 3,000 | 22.86 USD | |
| 16 Apr 2026 | EXERCISE | Apogee Therapeutics, Inc. | 3,000 | 0.00 USD | deriv |
| 11 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 8,219 | 74.83 USD | |
| 11 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 3,418 | 75.86 USD | |
| 11 Mar 2026 | SALE | Apogee Therapeutics, Inc. | 8,363 | 74.29 USD | |
| 11 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 11,494 | 62.96 USD | |
| 11 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 955 | 64.99 USD | |
| 11 Feb 2026 | SALE | Apogee Therapeutics, Inc. | 7,551 | 63.73 USD | |
| 21 Jan 2026 | OTHER | Spyre Therapeutics, Inc. | 63,227 | 0.00 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 8,476 | 79.82 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 2,374 | 81.00 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 1,854 | 82.41 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 470 | 83.79 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 1,440 | 78.64 USD | |
| 14 Jan 2026 | SALE | Apogee Therapeutics, Inc. | 5,386 | 83.16 USD | |
| 02 Jan 2026 | GRANT_AWARD | Apogee Therapeutics, Inc. | 253,016 | 0.00 USD | deriv |
| 10 Dec 2025 | SALE | Apogee Therapeutics, Inc. | 9,435 | 74.88 USD | |
| 10 Dec 2025 | SALE | Apogee Therapeutics, Inc. | 10,005 | 75.79 USD |